99 related articles for article (PubMed ID: 20647353)
1. Preparation of pseudotyped lentiviral vectors resistant to inactivation by serum complement.
Guibinga GH; Friedmann T
Cold Spring Harb Protoc; 2010 Jul; 2010(7):pdb.prot5420. PubMed ID: 20647353
[TBL] [Abstract][Full Text] [Related]
2. Baculovirus GP64-pseudotyped HIV-based lentivirus vectors are stabilized against complement inactivation by codisplay of decay accelerating factor (DAF) or of a GP64-DAF fusion protein.
Guibinga GH; Friedmann T
Mol Ther; 2005 Apr; 11(4):645-51. PubMed ID: 15771967
[TBL] [Abstract][Full Text] [Related]
3. Complement regulatory proteins are incorporated into lentiviral vectors and protect particles against complement inactivation.
Schauber-Plewa C; Simmons A; Tuerk MJ; Pacheco CD; Veres G
Gene Ther; 2005 Feb; 12(3):238-45. PubMed ID: 15550926
[TBL] [Abstract][Full Text] [Related]
4. Incorporation of decay-accelerating factor into the baculovirus envelope generates complement-resistant gene transfer vectors.
Hüser A; Rudolph M; Hofmann C
Nat Biotechnol; 2001 May; 19(5):451-5. PubMed ID: 11329015
[TBL] [Abstract][Full Text] [Related]
5. Acquisition of complement resistance through incorporation of CD55/decay-accelerating factor into viral particles bearing baculovirus GP64.
Kaname Y; Tani H; Kataoka C; Shiokawa M; Taguwa S; Abe T; Moriishi K; Kinoshita T; Matsuura Y
J Virol; 2010 Apr; 84(7):3210-9. PubMed ID: 20071581
[TBL] [Abstract][Full Text] [Related]
6. RD114 envelope proteins provide an effective and versatile approach to pseudotype lentiviral vectors.
Bell AJ; Fegen D; Ward M; Bank A
Exp Biol Med (Maywood); 2010 Oct; 235(10):1269-76. PubMed ID: 20876083
[TBL] [Abstract][Full Text] [Related]
7. Lentiviral vectors pseudotyped with baculovirus gp64 efficiently transduce mouse cells in vivo and show tropism restriction against hematopoietic cell types in vitro.
Schauber CA; Tuerk MJ; Pacheco CD; Escarpe PA; Veres G
Gene Ther; 2004 Feb; 11(3):266-75. PubMed ID: 14737086
[TBL] [Abstract][Full Text] [Related]
8. Production of lentiviral vectors by large-scale transient transfection of suspension cultures and affinity chromatography purification.
Segura MM; Garnier A; Durocher Y; Coelho H; Kamen A
Biotechnol Bioeng; 2007 Nov; 98(4):789-99. PubMed ID: 17461423
[TBL] [Abstract][Full Text] [Related]
9. Stabilization of gammaretroviral and lentiviral vectors: from production to gene transfer.
Carmo M; Alves A; Rodrigues AF; Coroadinha AS; Carrondo MJ; Alves PM; Cruz PE
J Gene Med; 2009 Aug; 11(8):670-8. PubMed ID: 19507176
[TBL] [Abstract][Full Text] [Related]
10. Novel bovine lentiviral vectors based on Jembrana disease virus.
Metharom P; Takyar S; Xia HH; Ellem KA; Macmillan J; Shepherd RW; Wilcox GE; Wei MQ
J Gene Med; 2000; 2(3):176-85. PubMed ID: 10894263
[TBL] [Abstract][Full Text] [Related]
11. Influenza M2 envelope protein augments avian influenza hemagglutinin pseudotyping of lentiviral vectors.
McKay T; Patel M; Pickles RJ; Johnson LG; Olsen JC
Gene Ther; 2006 Apr; 13(8):715-24. PubMed ID: 16397505
[TBL] [Abstract][Full Text] [Related]
12. Lentiviral vectors for delivery of genes into neonatal and adult ventricular cardiac myocytes in vitro and in vivo.
Zhao J; Pettigrew GJ; Thomas J; Vandenberg JI; Delriviere L; Bolton EM; Carmichael A; Martin JL; Marber MS; Lever AM
Basic Res Cardiol; 2002 Sep; 97(5):348-58. PubMed ID: 12200634
[TBL] [Abstract][Full Text] [Related]
13. VSV-G pseudotyped lentiviral vector particles produced in human cells are inactivated by human serum.
DePolo NJ; Reed JD; Sheridan PL; Townsend K; Sauter SL; Jolly DJ; Dubensky TW
Mol Ther; 2000 Sep; 2(3):218-22. PubMed ID: 10985952
[TBL] [Abstract][Full Text] [Related]
14. Multiply attenuated, self-inactivating lentiviral vectors efficiently transduce human coronary artery cells in vitro and rat arteries in vivo.
Céfaï D; Simeoni E; Ludunge KM; Driscoll R; von Segesser LK; Kappenberger L; Vassalli G
J Mol Cell Cardiol; 2005 Feb; 38(2):333-44. PubMed ID: 15698840
[TBL] [Abstract][Full Text] [Related]
15. Efficient transduction of neurons using Ross River glycoprotein-pseudotyped lentiviral vectors.
Jakobsson J; Nielsen TT; Staflin K; Georgievska B; Lundberg C
Gene Ther; 2006 Jun; 13(12):966-73. PubMed ID: 16511527
[TBL] [Abstract][Full Text] [Related]
16. Neuron-specific gene transfer through retrograde transport of lentiviral vector pseudotyped with a novel type of fusion envelope glycoprotein.
Kato S; Kuramochi M; Takasumi K; Kobayashi K; Inoue K; Takahara D; Hitoshi S; Ikenaka K; Shimada T; Takada M; Kobayashi K
Hum Gene Ther; 2011 Dec; 22(12):1511-23. PubMed ID: 21806473
[TBL] [Abstract][Full Text] [Related]
17. Lentiviral and MLV based retroviral vectors for ex vivo and in vivo gene transfer.
Blesch A
Methods; 2004 Jun; 33(2):164-72. PubMed ID: 15121171
[TBL] [Abstract][Full Text] [Related]
18. Lentiviral vectors pseudotyped with envelope glycoproteins derived from human parainfluenza virus type 3.
Jung C; Grzybowski BN; Tong S; Cheng L; Compans RW; Le Doux JM
Biotechnol Prog; 2004; 20(6):1810-6. PubMed ID: 15575716
[TBL] [Abstract][Full Text] [Related]
19. (Strept)avidin-displaying lentiviruses as versatile tools for targeting and dual imaging of gene delivery.
Kaikkonen MU; Lesch HP; Pikkarainen J; Räty JK; Vuorio T; Huhtala T; Taavitsainen M; Laitinen T; Tuunanen P; Gröhn O; Närvänen A; Airenne KJ; Ylä-Herttuala S
Gene Ther; 2009 Jul; 16(7):894-904. PubMed ID: 19440224
[TBL] [Abstract][Full Text] [Related]
20. Critical factors influencing stable transduction of human CD34(+) cells with HIV-1-derived lentiviral vectors.
Haas DL; Case SS; Crooks GM; Kohn DB
Mol Ther; 2000 Jul; 2(1):71-80. PubMed ID: 10899830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
